10 mg per vial
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
(Focuses on liposomal delivery for nutraceuticals like polyphenols.) 37
(7) V E Ryzhenkov, R P Ogurtsov, V V Trubacheva, V G Popov, and V P Puzyreva (1988) [Effect of thymalin on the development of experimental hyperlipidemia and atherosclerosis] Vopr Med Khim, 1988 Jan-Feb, Volume 34 (Issue 1), Pages 51-6
Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility
The Wolverine Stack is BPC-157 + TB-500 at injury-grade doses (500750 mcg BPC-157 daily, 35 mg TB-500 twice weekly) for tendon, ligament, and muscle repair
